Norman J E, Shepherd K M, Dale B M, Sage R E
Pathology. 1981 Jul;13(3):609-14. doi: 10.3109/00313028109059080.
Buffy coat cells were collected by leukapheresis from 14 patients with C.G.L. and one patient with M.M.M. Six of the C.G.L. patients had received busulphan at intervals varying between 401 and 38 d before leukapheresis. Significantly more CFUc's could be collected per leukapheresis in untreated patients and in those patients not treated within 105 d prior to leukapheresis. Survival of CFUc's following freezing was significantly less in the 3 most recently treated patients. These results suggest that in C.G.L. patients recently treated with busulphan, both the number of CFUc's in the peripheral blood and the ability of these cells to survive the freeze thaw process are reduced. However, sufficient CFUc's could theoretically be collected, stored and recovered post-thaw from one leukapheresis to allow complete haematopoietic restoration in all but 2 patients.
通过白细胞单采术从14例慢性粒细胞白血病(C.G.L.)患者和1例毛细胞白血病(M.M.M.)患者中采集了血沉棕黄层细胞。14例C.G.L.患者中有6例在白细胞单采术前401天至38天期间间隔接受了白消安治疗。在未治疗的患者以及在白细胞单采术前105天内未接受治疗的患者中,每次白细胞单采术可采集到的集落形成单位 - 细胞(CFUc)明显更多。在最近接受治疗的3例患者中,冷冻后CFUc的存活率明显更低。这些结果表明,在近期接受白消安治疗的C.G.L.患者中,外周血中CFUc的数量以及这些细胞在冻融过程中存活的能力均降低。然而,理论上从一次白细胞单采术中采集、储存并在解冻后回收的CFUc足以使除2例患者外的所有患者实现完全造血恢复。